Skip to content

13F-HR filed by Avoro Capital Advisors LLC

Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2015-06-30, filed 2015-08-14, with 31 holding rows worth $363,116,000.

Accession
0001144204-15-049536
Filed
2015-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2015

A holdings report, 31 entries on the cover page, a total value of $363,116,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $363,116,000 with VALUE read as thousands by filing date, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AMICUS THERAPEUTICS INC03152W109COM4,590,199$64,951,000thousands by filing date
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK2,186,520$38,526,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM1,000,000$31,470,000thousands by filing date
Lion Biotechnologies53619R102COM2,923,065$26,805,000thousands by filing date
ONCOTHYREON INC682324108COM5,617,003$21,008,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM495,000$20,731,000thousands by filing date
AGENUS INC00847G705COM NEW2,199,137$18,979,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM1,438,693$18,257,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2611,999$15,000,000thousands by filing date
IGI LABORATORIES INC449575109COM1,753,682$11,048,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM352,350$8,886,000thousands by filing date
VERACYTE INC COM92337F107Stock758,497$8,450,000thousands by filing date
PERNIX THERAPEUTICS HOLDINGS71426V108COM1,250,167$7,401,000thousands by filing date
Innocoll45780Q103SPONDS ADR497,422$7,277,000thousands by filing date
AXOVANT SCIENCES LTDG0750W104COM340,000$6,929,000thousands by filing date
TONIX PHARMACEUTICALS HOLDING890260201COM NEW755,300$6,775,000thousands by filing date
NEURODERM LTDM74231107ORD SHS371,111$5,697,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON267,747$5,674,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM262,515$5,584,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK26,500$5,036,000thousands by filing date
HERON THERAPEUTICS INC427746102COM150,000$4,674,000thousands by filing date
Alliqua BioMedical Inc019621200COM NEW800,000$4,216,000thousands by filing date
VERICEL CORP92346J108COM1,083,486$3,868,000thousands by filing date
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR183,900$3,371,000thousands by filing date
FORTRESS BIOTECH INC34960Q109COM929,531$3,123,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock94,400$2,060,000thousands by filing date
HEAT BIOLOGICS INC42237K102COM335,102$2,011,000thousands by filing date
BIOGEN INC COM09062X103Stock4,500$1,818,000thousands by filing date
TARGACEPT INC87611R306COM587,315$1,639,000thousands by filing date
CELLECTIS ADS15117K103COM30,000$1,082,000thousands by filing date
SPDR SERIES TRUST78464A950PUT350,000$770,000thousands by filing dateput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001144204-15-049536this filing2015-08-14acceptance time not in the bulk data set